Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A Model to Estimate the Unmedicated Intraocular Pressure of Patients on Glaucoma Medications

View through CrossRef
Précis: This report presents a model which can be used to determine the IOP-lowering effect of a glaucoma procedure or treatment when a medication washout is not ethical or not possible to be performed. Background: The effect of individual (or certain predefined combinations of) glaucoma medications on intraocular pressure (IOP) has been well documented in various clinical trials. Conversely, the cumulative effect of several glaucoma medications, let alone their discontinuation (i.e. washout), on IOP is still relatively unknown. This is why it is generally recommended to perform a medications’ washout to analyze the effect of glaucoma procedure without confounding factors. However, a washout is not always possible or ethical for some patients and can also increase the costs and complexity of clinical trials. Aims: To build and validate a mathematical model of the IOP change after glaucoma medications washout. Method: A literature search was conducted to identify studies reporting IOP values before and after washout, as well as the number of glaucoma medications used. Based on this, a quadratic equation was fitted to estimate the IOP change after washout, using the mean medicated IOP and the mean number of medications as input parameters. Findings: A total of 31 groups (each group having a precise mean medicated IOP, mean number of medications, and mean post washout IOP) from 15 studies were selected to build and validate the model. Overall, over 90% of the variability of IOP change reported in the studies was explained by the model (R2=0.9007). The mean difference between the IOP changes estimated by the model and the IOP changes reported in the studies was less than 1 mmHg. Conclusion: Estimating the IOP change using this model may represent an useful tool to determine the IOP-lowering effect of a glaucoma procedure or treatment when the washout is not ethical or not possible to be performed on patients. More studies need to be conducted to validate the practical robustness of this formula.
Title: A Model to Estimate the Unmedicated Intraocular Pressure of Patients on Glaucoma Medications
Description:
Précis: This report presents a model which can be used to determine the IOP-lowering effect of a glaucoma procedure or treatment when a medication washout is not ethical or not possible to be performed.
Background: The effect of individual (or certain predefined combinations of) glaucoma medications on intraocular pressure (IOP) has been well documented in various clinical trials.
Conversely, the cumulative effect of several glaucoma medications, let alone their discontinuation (i.
e.
washout), on IOP is still relatively unknown.
This is why it is generally recommended to perform a medications’ washout to analyze the effect of glaucoma procedure without confounding factors.
However, a washout is not always possible or ethical for some patients and can also increase the costs and complexity of clinical trials.
Aims: To build and validate a mathematical model of the IOP change after glaucoma medications washout.
Method: A literature search was conducted to identify studies reporting IOP values before and after washout, as well as the number of glaucoma medications used.
Based on this, a quadratic equation was fitted to estimate the IOP change after washout, using the mean medicated IOP and the mean number of medications as input parameters.
Findings: A total of 31 groups (each group having a precise mean medicated IOP, mean number of medications, and mean post washout IOP) from 15 studies were selected to build and validate the model.
Overall, over 90% of the variability of IOP change reported in the studies was explained by the model (R2=0.
9007).
The mean difference between the IOP changes estimated by the model and the IOP changes reported in the studies was less than 1 mmHg.
Conclusion: Estimating the IOP change using this model may represent an useful tool to determine the IOP-lowering effect of a glaucoma procedure or treatment when the washout is not ethical or not possible to be performed on patients.
More studies need to be conducted to validate the practical robustness of this formula.

Related Results

Childhood glaucoma profile in a Southwestern Ethiopia tertiary care center: a retrospective study
Childhood glaucoma profile in a Southwestern Ethiopia tertiary care center: a retrospective study
Abstract Background Childhood glaucoma is a major cause of childhood blindness worldwide. The profile of childhood glaucoma has not been well characterized in sub-Saharan ...
Profile of Newly Referred Glaucoma Patients to the Largest Tertiary Eye Care Hospital in Saudi Arabia
Profile of Newly Referred Glaucoma Patients to the Largest Tertiary Eye Care Hospital in Saudi Arabia
Abstract Purpose: To report the profile of newly referred glaucoma patients to the largest tertiary eye care hospital in Saudi Arabia. Patients and Methods: Medical record...
Cross-sectional Survey to Determine the Awareness and Uptake of Glaucoma Surgery
Cross-sectional Survey to Determine the Awareness and Uptake of Glaucoma Surgery
Introduction : This study aimed to determine the awareness and uptake of surgery as a treatment option in patients with glaucoma on medical treatment. ...
Trend of glaucoma internal filtration surgeries in a tertiary hospital in China
Trend of glaucoma internal filtration surgeries in a tertiary hospital in China
AIM: To evaluate the trend of glaucoma internal filtration surgeries for inpatients between 2015 and 2021 at the Eye Hospital of Wenzhou Medical University. METHODS: A review of th...
Drug-induced (toxic) glaucoma
Drug-induced (toxic) glaucoma
Glaucoma is the leading cause of irreversible blindness in the world and the second most common cause of blindness overall. The prevalence of glaucoma is approximately 3% of the po...
Profile of pediatric glaucoma patients in Shanghai Eye, Ear, Nose and Throat Hospital
Profile of pediatric glaucoma patients in Shanghai Eye, Ear, Nose and Throat Hospital
BackgroundThe extent of our knowledge of the epidemiology of pediatric glaucoma in China is limited. To better characterize the epidemiology of pediatric glaucoma in eastern China,...
A clinical study of secondary glaucoma
A clinical study of secondary glaucoma
Secondary Glaucoma is a group of disorders in which raised intraocular pressure is associated with some primary ocular or systemic cause. This prospective study aims to evaluate th...

Back to Top